{"id":420217,"date":"2021-01-25T08:33:20","date_gmt":"2021-01-25T13:33:20","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=420217"},"modified":"2021-01-25T08:33:20","modified_gmt":"2021-01-25T13:33:20","slug":"caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\/","title":{"rendered":"Caladrius Biosciences Announces Participation in Upcoming Virtual Conferences in February 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BASKING RIDGE, N.J., Jan.  25, 2021  (GLOBE NEWSWIRE) &#8212; Caladrius Biosciences, Inc. (Nasdaq: CLBS) (\u201cCaladrius\u201d or the \u201cCompany\u201d),\u00a0a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced its participation in the following virtual conferences in February.<\/p>\n<p align=\"left\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EtzJNqSh0h_nNNwBnVvT6v5jxjJsMzTMdn4W9fOsHnbNCA3i-PjvYR_jLuWzBKYt1IyI8nCnTGuylGotuVGYxEPXyqbgEXZRD-GtVyB-BI2NHQ2SpWAC4-Pud3yLonQ5WHfkVlq3W7nHfcbUOXsfMoFloVyyxycJLwtAUAfF3JM=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n          <strong>LSX World Congress Virtual, February 1-5, 2021<\/strong><br \/>\n        <\/a><br \/>\n        <br \/>Presenter: David J. Mazzo, PhD, President and Chief Executive Officer<\/p>\n<p align=\"left\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GCvdrKCf3izJCpWf6siGAJ1JbL9YwUxMZrgvPeskNAeyk35e8XPcHq_VklJE-Xm_Noy6agiVkJuRtmYdN9yqYix6sGUpLxxKX1GCpQzoU4IJFoI6-0phEt_caHJidlmmmPL3si4f8CVsSayH_BzRYOuxmhzrWE16Ldfsoy-UtLk=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n          <strong>Charlotte CIO Executive Leadership Summit, February 4, 2021<\/strong><br \/>\n        <\/a><br \/>\n        <br \/>Presenter: Greg S. Berkin, Vice President of IT &amp; Cybersecurity and Chief Information Officer<\/p>\n<p align=\"left\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xdqhv4xpeT-Ln9bZv8iTZId9vKZcBfrG_PMjzDyBCFZz97q5ZDbpfPVwz9fZ4FRFj4V8EU97rlFEytUtlNTdUgXW-2_cDSi4LygEMBgMcYgc1oXuw4CmVHanFW4MyhhSsaFtHVw8kNs1xj_LMSU_Mqs6UEqcTWuaEpUjSkYrcOjglINLqMNaYSCAex2mDp_vpRnZObqOBu3zTRUlNbArog==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n          <strong>BIO CEO &amp; Investor Digital Conference, February 16-18, 2021<\/strong><br \/>\n        <\/a><br \/>\n        <br \/>Presenter: David J. Mazzo, PhD, President and Chief Executive Officer<\/p>\n<p align=\"left\">\n        <em>To inquire about arranging a meeting with management during the LSX World Congress and\/or the BIO CEO &amp; Investor conference, please contact John Menditto, VP of IR and Corporate Communications, at <\/em><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zb9R9Qu4gVvuEh9oPRUd8id9fcqHekDMsFP0F7kfBj87IcT_Rbm1VMbmfr2ep5Goh0pmS3zKYw_oGqwdYJa0eHG2d2Z600hVbHQh73bTA2g=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n          <em>jmenditto@caladrius.com<\/em><br \/>\n        <\/a><br \/>\n        <em>. <\/em>\n      <\/p>\n<p align=\"left\">\n        <strong>About Caladrius Biosciences<\/strong>\n      <\/p>\n<p align=\"left\">Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease. We are developing first-in-class cell therapy products based on the finely tuned mechanisms for self-repair that exist in the human body. Our technology leverages and enables these mechanisms in the form of specific cells, using formulations and modes of delivery unique to each medical indication.<\/p>\n<p align=\"left\">The Company\u2019s current product candidates include: HONEDRA\u00ae (formerly CLBS12), recipient of SAKIGAKE designation and eligible for early conditional approval in Japan for the treatment of critical limb ischemia (\u201cCLI\u201d) based on the results of an ongoing clinical trial; OLOGO\u2122 (formerly CLBS14), a Regenerative Medicine Advanced Therapy (\u201cRMAT\u201d) designated therapy for which the Company has finalized with the U.S. Food and Drug Administration (the \u201cFDA\u201d) a protocol for a Phase 3 confirmatory trial in subjects with no-option refractory disabling angina (\u201cNORDA\u201d); CLBS16, the subject of both a recently completed positive Phase 2a study and a newly initiated Phase 2b study in the U.S. for the treatment of coronary microvascular dysfunction (\u201cCMD\u201d); CLBS119, an emergent CD34+ stem cell therapy responding to the COVID-19 pandemic and the potentially permanent damage the virus inflicts on the lungs of many patients; and CLBS201, designed to assess the safety and efficacy of CD34+ cell therapy as a treatment for chronic kidney disease (\u201cCKD\u201d). For more information on the company, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=a6Qsu7PJihtFaTjpXaCU5oGlkFWdptwB0Z0LwD8QFVChQ5G4usxHHiHLdUU970OssCeuxoYvrOX8WG5b9CsQQg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.caladrius.com<\/a>.<\/p>\n<p align=\"left\">\n        <strong>Contact:<\/strong>\n      <\/p>\n<p align=\"left\">Investors:<br \/>Caladrius Biosciences, Inc.<br \/>John Menditto<br \/>Vice President, Investor Relations and Corporate Communications<br \/>Phone: +1-908-842-0084<br \/>Email:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zb9R9Qu4gVvuEh9oPRUd8id9fcqHekDMsFP0F7kfBj99ZxBlOgfJp6rT2_vzUu7SQkKz4ZiMzcXR1pyvKjThQXlaPP2aBxEIarVObVi4Esg=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">jmenditto@caladrius.com<\/a><\/p>\n<p align=\"left\">Media:<br \/>W2O Group<br \/>Christiana Pascale<br \/>Phone: +1-212-257-6722<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5nw-QERHMWsE1JXbuEU5A3uabWKYElo1IZI9QOFupgoqy1yVdYzVd8Viuz0Z3HadXYLZn0sOCVTKpNG0y7QlSD7Cvx12STBRQVc78ecXZdY=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">cpascale@w2ogroup.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE0MDI3NiMzOTQxMjE3IzIwMjExNTI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/0bda6c58-4ba8-4fa0-b63a-15f85d19a7b2\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BASKING RIDGE, N.J., Jan. 25, 2021 (GLOBE NEWSWIRE) &#8212; Caladrius Biosciences, Inc. (Nasdaq: CLBS) (\u201cCaladrius\u201d or the \u201cCompany\u201d),\u00a0a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced its participation in the following virtual conferences in February. LSX World Congress Virtual, February 1-5, 2021 Presenter: David J. Mazzo, PhD, President and Chief Executive Officer Charlotte CIO Executive Leadership Summit, February 4, 2021 Presenter: Greg S. Berkin, Vice President of IT &amp; Cybersecurity and Chief Information Officer BIO CEO &amp; Investor Digital Conference, February 16-18, 2021 Presenter: David J. Mazzo, PhD, President and Chief Executive Officer To inquire about arranging a meeting with management during the LSX World Congress and\/or the BIO CEO &amp; Investor &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Caladrius Biosciences Announces Participation in Upcoming Virtual Conferences in February 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-420217","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Caladrius Biosciences Announces Participation in Upcoming Virtual Conferences in February 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Caladrius Biosciences Announces Participation in Upcoming Virtual Conferences in February 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BASKING RIDGE, N.J., Jan. 25, 2021 (GLOBE NEWSWIRE) &#8212; Caladrius Biosciences, Inc. (Nasdaq: CLBS) (\u201cCaladrius\u201d or the \u201cCompany\u201d),\u00a0a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced its participation in the following virtual conferences in February. LSX World Congress Virtual, February 1-5, 2021 Presenter: David J. Mazzo, PhD, President and Chief Executive Officer Charlotte CIO Executive Leadership Summit, February 4, 2021 Presenter: Greg S. Berkin, Vice President of IT &amp; Cybersecurity and Chief Information Officer BIO CEO &amp; Investor Digital Conference, February 16-18, 2021 Presenter: David J. Mazzo, PhD, President and Chief Executive Officer To inquire about arranging a meeting with management during the LSX World Congress and\/or the BIO CEO &amp; Investor &hellip; Continue reading &quot;Caladrius Biosciences Announces Participation in Upcoming Virtual Conferences in February 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-25T13:33:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE0MDI3NiMzOTQxMjE3IzIwMjExNTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Caladrius Biosciences Announces Participation in Upcoming Virtual Conferences in February 2021\",\"datePublished\":\"2021-01-25T13:33:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\\\/\"},\"wordCount\":412,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE0MDI3NiMzOTQxMjE3IzIwMjExNTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\\\/\",\"name\":\"Caladrius Biosciences Announces Participation in Upcoming Virtual Conferences in February 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE0MDI3NiMzOTQxMjE3IzIwMjExNTI=\",\"datePublished\":\"2021-01-25T13:33:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE0MDI3NiMzOTQxMjE3IzIwMjExNTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE0MDI3NiMzOTQxMjE3IzIwMjExNTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Caladrius Biosciences Announces Participation in Upcoming Virtual Conferences in February 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Caladrius Biosciences Announces Participation in Upcoming Virtual Conferences in February 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\/","og_locale":"en_US","og_type":"article","og_title":"Caladrius Biosciences Announces Participation in Upcoming Virtual Conferences in February 2021 - Market Newsdesk","og_description":"BASKING RIDGE, N.J., Jan. 25, 2021 (GLOBE NEWSWIRE) &#8212; Caladrius Biosciences, Inc. (Nasdaq: CLBS) (\u201cCaladrius\u201d or the \u201cCompany\u201d),\u00a0a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced its participation in the following virtual conferences in February. LSX World Congress Virtual, February 1-5, 2021 Presenter: David J. Mazzo, PhD, President and Chief Executive Officer Charlotte CIO Executive Leadership Summit, February 4, 2021 Presenter: Greg S. Berkin, Vice President of IT &amp; Cybersecurity and Chief Information Officer BIO CEO &amp; Investor Digital Conference, February 16-18, 2021 Presenter: David J. Mazzo, PhD, President and Chief Executive Officer To inquire about arranging a meeting with management during the LSX World Congress and\/or the BIO CEO &amp; Investor &hellip; Continue reading \"Caladrius Biosciences Announces Participation in Upcoming Virtual Conferences in February 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-25T13:33:20+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE0MDI3NiMzOTQxMjE3IzIwMjExNTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Caladrius Biosciences Announces Participation in Upcoming Virtual Conferences in February 2021","datePublished":"2021-01-25T13:33:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\/"},"wordCount":412,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE0MDI3NiMzOTQxMjE3IzIwMjExNTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\/","name":"Caladrius Biosciences Announces Participation in Upcoming Virtual Conferences in February 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE0MDI3NiMzOTQxMjE3IzIwMjExNTI=","datePublished":"2021-01-25T13:33:20+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE0MDI3NiMzOTQxMjE3IzIwMjExNTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE0MDI3NiMzOTQxMjE3IzIwMjExNTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caladrius-biosciences-announces-participation-in-upcoming-virtual-conferences-in-february-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Caladrius Biosciences Announces Participation in Upcoming Virtual Conferences in February 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/420217","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=420217"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/420217\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=420217"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=420217"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=420217"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}